Human papillomavirus prevalence in pregnancy

Obstetrics and Gynecology

Volumn 79, Issue 5, 1992, Pages 649-656

  Kemp, Elizabeth A ^a,b   Hakenewerth, Anne M ^a,b   Laurent, Sherry L ^a,b   Gravitt, Patti E ^a,b   Stoerker, Jay ^a,b  

^a CAROLINAS MEDICAL CENTER   (United States)

^b UNIVERSITY OF NORTH CAROLINA AT CHARLOTTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PAPILLOMA VIRUS; PRIORITY JOURNAL; UTERINE CERVIX; VIRUS INFECTION;

ADULT; CERVIX DYSPLASIA; CONDYLOMATA ACUMINATA; FEMALE; GENITAL NEOPLASMS, FEMALE; HUMAN; PAPILLOMAVIRUS; POLYMERASE CHAIN REACTION; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY COMPLICATIONS, NEOPLASTIC; PREVALENCE; RISK FACTORS; SUPPORT, NON-U.S. GOV'T; TUMOR VIRUS INFECTIONS; VAGINA;

EID: 0026593939     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Centers for Disease Control. Condyloma acuminatum–United States. MMWR 1983;32:306-8.
2. Meisels A, Fortin R, Roy M. Condylomatous lesions of the cervix and vagina. Acta Cytol 1977;21:379-83.
3. Reid R, Laverty CR, Coppelson M, Isarangkul W, Hills E. Noncondylomatous cervical wart virus infection. Obstet Gynecol 1980;55:476-83.
4. Kirkup W, Evans AS, Brough AK, et al. Cervical intraepithelial neoplasia and “warty” atypia: A study of colposcopic, histological, and cytological characteristics. Br J Obstet Gynaecol 1982;89: 571-7.
5. Durst M, Gissmann L, Ikenberg H, zur Hausen H. A papillomavirus DNA from cervical carcinoma and its prevalence in cancer biopsies from different geographic regions. Proc Natl Acad Sci USA 1983;80:3812-7.
6. Boshart M, Gissmann L, Ikenberg H, Kleinheinz A, Scheurlen W, zur Hausen H. A new type of papillomavirus DNA, its presence in cervical cancer biopsies and in cell lines derived from cervical cancer. EMBO J 1984;3:1151-7.
7. Lorincz AT. Human papillomavirus detection tests. In: Holmes K, et al, eds. Sexually transmitted diseases. 2nd ed. New York: McGraw Hill, 1989:953-9.
8. de Villiers E-M, Wagner D, Schneider A, et al. Human papillomavirus infections in women with and without abnormal cervical cytology. Lancet 1987;2:703-6.
9. Becker TM, Stone KM, Alexander ER. Genital human papillomavirus infection. Obstet Gynecol Clin North Am 1987;14:389-95.
10. Fife KH, Rogers RE, Zwicki BW. Symptomatic and asymptomatic cervical infections with human papillomavirus during pregnancy. J Infect Dis 1987;156:904-11.
11. Brandsma J, Burk RD, Lancaster WD, Pfister H, Schiffman MH. Inter-laboratory variation as an explanation for varying prevalence estimates of human papillomavirus infections. Int J Cancer 1989;43:260-2.
12. Roman A, Fife KH. Human papillomaviruses: Are we ready to type? Clin Microbiol Rev 1989;2:166-90.
13. Bauer HM, Ting Y, Greer CE. Genital human papillomavirus infection in female university, students as determined by a PCR based method. JAMA 1991;265:472-7.
14. Schiffman MH, Bauer HM, Lorincz AT, et al. A comparison of J Southern blot hybridization and PCR methods for the detection of human papillomavirus DNA. J Clin Microbiol 1991;29:573-7.
15. Gravitt P, Hakenewerth A, Stoerker J. A direct comparison of methods proposed for use in widespread screening of human, papillomavirus infections. Mol Cell Probes 1991;5:152-7.
16. Franco EL. The sexually transmitted disease model for cervical cancer: Incoherent epidemiologic findings and the role of misclas-sification of HPV infection. Epidemiology 1991;2:98-104.
17. Reeves WC, Brinton LA, Garcia M, et al. Human papillomavirus. infection and cervical cancer in Latin America. N Engl J Med. 1989;320:1437-41.
18. Rosenfeld RD, Vermund SH, Wentz SJ, Burk RD. High prevalence rate of human papillomavirus infection and association with abnormal Papanicolaou smears in sexually active adolescents, Am J Dis Child 1989;143:1443-7.
19. Spradbrow PB. Immune response to papillomavirus infection. In: Syrjanen K, Koss LG, eds. Papillomaviruses and human disease. Heidelberg: Springer Verlag, 1987:334-46.
20. Rando RF, Lindheim S, Hasty L, Sedlacek TV, Woodland M, Eder C. Increased frequency of detection of human papillomavirus DNA in exfoliated cervical cells during pregnancy. Am J Obstet Gynecol 1989;161:50-5.
21. Schneider A, Hotz M, Gissmann L. Increased prevalence of, human papillomavirus in the lower genital tract of pregnant women. Int J Cancer 1987;40:198-203.
22. Manos MM, Ting Y, Wright DK, et al. Use of polymerase chain reaction amplification for the detection of genital human papillo-maviruses. Cancer cells 7, molecular diagnostics of human cancer. New York: CSH Laboratory Press, 1989:209-14.
23. Highsmith WE, Perry TR, Prior TW, Silverman LM. The use of polymerase chain reaction for simultaneous analysis of two PstI polymorphisms linked to cystic fibrosis. Clin Chem 1989;35: 1260-1.
24. West JR, Perry HO. Pregnancy: Another treatment for warts? Arch Dermatol 1961;84:187-8.
25. ViraPap package insert. Bethesda, Maryland: Digene Diagnostics Inc, p 18.
26. Naghashfar ZS, Rosenshein NB, Lorincz AT, Buscema J, Shah KV. Characterization of HPV type 45, a new type 18-related virus of the genital tract. J Gen Virol 1987;68:3073-9.
27. Lorincz AT, Quinn AP, Goldsbrough MD, McAllister P. HPV type 56: A new virus detected in cervical cancers. J Gen Virol; 1989;70:3099-104.
28. Ley C, Bauer HM, Reingold A, et al. Determinants of genital human papillomavirus infection in young women. J Natl Cancer Inst 1991;83:997-1003.
29. Herrero R, Brinton LA, Reeves WC, et al. Invasive cervical cancer and smoking in Latin America. J Natl Cancer Inst 1989;81:205-11.
30. Lorincz AT, Schiffman MH, Jaffurs WJ, Marlow J, Quinn AP, Temple GF. Temporal associations of HPV infection with cervical cytologic abnormality. Am J Obstet Gynecol 1990;162:645-51.
31. zur Hausen H. The role of papillomaviruses in anogenital cancer. Scand J Infect Dis Suppl 1990;69:107-11.
32. Mose Larsen P, Vetner M, Hansen K, Fey SJ. Future trends in cervical cancer. Cancer Lett 1988;41:123-37.
33. Rando RF. Human papillomavirus: Implications for clinical medicine. Ann Intern Med 1988;108:628-30.
34. Ferenczy A, Mitao M, Nagai N, et al. Latent papillomavirus and recurring genital warts. N Engl J Med 1985;313:784-9.
35. Nuovo GJ, Pedemonte BM. Human papillomavirus types and recurrent cervical warts. JAMA 1990;263:1223-6.